STRATASYS LTD. director Yuval Cohen filed an initial Form 3 detailing his beneficial ownership in the company. The filing reports direct holdings of ordinary shares and stock options, along with substantial indirect holdings through affiliated investment partnerships.
Directly, Cohen holds ordinary shares and a stock option covering 11,056 ordinary shares at an exercise price of $11.45 per share, expiring on September 30, 2035. Indirectly, he reports 11,650,485 ordinary shares held by FF6-SSYS, Limited Partnership and 1,346,200 ordinary shares held by Fortissimo Capital Fund V, L.P. Footnotes explain that certain holdings consist of restricted share units and options granted on September 30, 2025 that vest in 12 equal monthly installments from April 8, 2025 through April 8, 2026.
STRATASYS LTD. director John Joseph McEleney filed an initial ownership report detailing his equity position in the company. The filing lists multiple stock option awards to buy ordinary shares, including grants with exercise prices of $21.44 and $9.50 per share that expire between 2026 and 2035, along with direct holdings of ordinary shares. Footnotes explain that certain ordinary shares come from restricted share units and options granted on September 30, 2025 that vest in 12 equal monthly installments from December 1, 2025 through December 1, 2026.
STRATASYS LTD. director Aris Kekedjian has filed an initial ownership report showing his existing equity position in the company. He holds stock options over 12,179 ordinary shares at an exercise price of $5.7500, 12,883 shares at $9.3200, and 11,056 shares at $11.4500, with expirations between 2033 and 2035. He also reports direct holdings of 13,073 and 6,113 ordinary shares. Footnotes state that certain ordinary shares are underlying RSUs granted on September 30, 2025 and that both these RSUs and related options vest in 12 equal monthly installments through November 16, 2026.
STRATASYS LTD. director Adina Shorr has filed an initial ownership report detailing her equity position in the company. The Form 3 shows direct holdings of ordinary shares, including 58,418 shares in one line item and 6,113 shares in another.
She also reports multiple stock option grants to buy ordinary shares at exercise prices ranging from $6.18 to $25.03, with expiration dates running from 2028 through 2035. A footnote explains that part of her ordinary share line represents restricted share units granted on September 30, 2025, which vest in 12 equal monthly installments from September 13, 2025 to September 13, 2026.
Stratasys Ltd. Chief Financial Officer Zamir Eitan filed an initial Form 3 reporting his beneficial ownership of ordinary shares. The filing lists several blocks of directly owned ordinary shares, including 40,739, 31,515, 40,000, 51,305 and 54,806 shares as of March 18, 2026. Footnotes explain that many of these amounts represent shares underlying restricted share units granted in 2023, 2024 and 2025 that vest over four-year schedules, with 25% vesting after one year and the remainder vesting quarterly.
STRATASYS LTD. director David M. Reis has filed an initial Form 3 reporting his equity holdings in the company. He directly holds ordinary shares, including 38,448 shares, and multiple stock option awards to acquire ordinary shares at exercise prices ranging from $6.18 to $25.03 with expirations between 2028 and 2035. Footnotes explain that a portion of the reported ordinary shares represents restricted share units granted on September 30, 2025 that vest in twelve equal monthly installments through June 24, 2026, and that an option grant from the same date also vests in twelve equal monthly installments over the same period.
STRATASYS LTD. director Ofer Dov filed an initial ownership report showing both share and option positions in the company. He holds 45,798 ordinary shares directly, plus another 6,113 ordinary shares reported in a separate line that a footnote explains relate to restricted share units granted on September 30, 2025, vesting monthly through July 18, 2026.
Dov also reports multiple stock option awards over ordinary shares with exercise prices between $6.18 and $25.03, expiring from July 18, 2027 to September 30, 2035. Examples include options over 37,500 ordinary shares at an exercise price of $22.28 per share and options over 11,056 ordinary shares at an exercise price of $11.45 per share. The filing reflects existing holdings rather than new market purchases or sales.
Stratasys Ltd. files its annual report outlining its 3D-printing business, key risks and recent financial developments for the year ended December 31, 2025. The company had 86,109,936 ordinary shares outstanding (excluding 266,018 treasury shares) as of that date.
Management highlights macro headwinds such as lingering inflation, moderately high interest rates, tighter credit and supply-chain interruptions, all weighing on customer capital spending and system demand. In response, Stratasys launched an August 2024 restructuring, cutting its workforce by about 15% and refocusing on higher-growth polymer applications, though it notes this has not yet driven revenue growth.
The report discloses a $33.9 million impairment in the third quarter of 2025 on its equity investment in Ultimaker, which materially increased that quarter’s GAAP loss. Goodwill and other intangibles totaled $197.4 million at year-end, down from $205.3 million a year earlier, and remain subject to further impairment testing.
Extensive risk factors cover technology disruption, pricing pressure, slower 3D-printing adoption, reliance on single-source suppliers, tariffs, global economic uncertainty, data-security threats, medical-device and environmental regulation, and geopolitical exposure to Israel’s conflicts. The company emphasizes forward-looking statements are uncertain and subject to these risks.
Stratasys Ltd. reported softer 2025 sales but improved profitability and cash generation, and issued 2026 guidance. Full-year 2025 revenue was $551.1 million versus $572.5 million in 2024, with a GAAP net loss of $104.3 million ($1.28 per share) and non-GAAP net income of $12.7 million ($0.15 per share). Adjusted EBITDA rose to $28.5 million, and operating cash flow reached $15.1 million, with year-end cash, equivalents and deposits of $244.5 million and no debt.
For 2026, Stratasys guides revenue to $565–$575 million, non-GAAP gross margin of 46.7%–47.1%, non-GAAP operating margin of 0.7%–1.5%, GAAP net loss of $(83) to $(67) million, non-GAAP net income of $8–$12.5 million and Adjusted EBITDA of $25–$30 million, while expecting positive operating cash flow.
Stratasys Ltd. furnished a Form 6-K to provide investors with its unaudited, condensed consolidated financial statements and related analysis for the three and nine months ended September 30, 2025. These materials present the company’s Q3 2025 financial position, operating results, and liquidity overview.
The filing includes detailed Q3 2025 financial statements, an operating and financial review, market risk disclosures, legal proceedings, and updated risk factors. Stratasys also supplies these statements in Inline XBRL format and incorporates this information by reference into multiple existing Form S-8 and Form F-3 registration statements.